… in immune-diagnosis and immunotherapy will be demonstrated, particularly for … been
discovered, as a trial for decreasing such adverse reactions and rise efficiency [55]. Immunotherapy …

… that a SARS-CoV-2–specific IL2/IL5 lymphokine ratio <1 conferred susceptibility to SARS-CoV-…
First, we focused on the quality of SARS-CoV-2–specific T-cell responses detected in 191 …

… , the advancement of immunotherapy, particularly monoclonal antibodies and … SARS-CoV-like
pathogen known to be widely distributed in the Malayan pangolin samples was discovered…

… discuss the immunotherapies available to manage the infection and the clinical outcomes. …
and dampening strategies, but other mechanisms may be discovered [130,134]. The major …

… SARS-CoV-2 is the causative virus and the infection as well as its symptoms are distributed
… On the other side, immunotherapeutic approaches aim to modulate the host immunity by fine …

… or ribavirin have all been successful in inhibiting SARS-CoV-2 in vitro. The initial … of SARS,
MERS, influenza, or in vitro studies. Meanwhile, scientists worldwide are seeking to discover …

… At the same time, studies are on roll to discover potent … rapid SARS-CoV-2 transmission
globally, much more investigations are needed for the development of effective immunotherapy. …

… (SARS) triggered the first global alert for coronavirus infections. … and human infections of
SARS coronavirus (SARS-CoV) have not been … SARS-CoV-like viruses have been discovered in …

… shown for instance that exposure to immunotherapy does not affect severity or mortality from
… , molecularly targeted therapies, and immunotherapy, does not adversely influence mortality …

… East respiratory syndrome coronavirus (MERS-CoV), such as … Whereas the trials on
SARS-CoV-2 genome-based specific … and those based on immunotherapy approaches either …